Table 4.
Tricyclic antidepressants dosing advice based on CYP2C19 and CYP2D6 phenotype according to DPWG and/or CPIC; see (78).
| TCAs | CYP2C19 | CYP2D6 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Poor metabolizer | Intermediate metabolizer | Normal metabolizer | Ultrarapid metabolizer | Poor metabolizer | Intermediate metabolizer | Normal metabolizer | Ultrarapid metabolizer | ||
| Amitriptyline | Nortriptyline/ desimpramine or 50% dose reduction |
Recommended starting dose | Recommended starting dose | Nortriptyline/ desimpramine or 50% dose increase |
No TCA or 50% | Reduce dose by 25% | Recommended starting dose | No TCA or higher dose | |
| Clomipramine | Nortriptyline/ desimpramine or 50% |
Recommended starting dose | Recommended starting dose | Nortriptyline/ desimpramine or 50% dose increase |
No TCA or 50% dose reduction | Reduce dose by 25% | Recommended starting dose | No TCA or higher dose | |
| Doxepine | Nortriptyline/ desimpramine or 50% |
Recommended starting dose | Recommended starting dose | Nortriptyline/ desimpramine or 50% |
Reduce dose by 60% | Reduce dose by 20% | Recommended starting dose | No TCA or 100% higher dose | |
| Imipramine | Nortriptyline/ desimpramine or 50% |
Recommended starting dose | Recommended starting dose | Nortriptyline/ desimpramine or 50% |
No TCA or 70% dose reduction | No TCA or 30% dose reduction | Recommended starting dose | No TCA or 70% dose increase | |
| Nortriptyline | Recommended starting dose | Recommended starting dose | 100% | No TCA or 60% dose reduction | No TCA or 40% dose reduction | Recommended starting dose | No TCA or 60% dose increase | ||